Quillivant XR 25 MG/5 ML susp 120ML
Ended Awarded
- Contract number
- SPE2DB25FSBWY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,860
Award facts
- Contract value 100% obligated
- $1,859.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,859.94 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 mL suspension in a 120 mL container. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 31, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion through December 2026.
Quillivant XR is a brand-name extended-release formulation of methylphenidate used to treat attention-deficit/hyperactivity disorder (ADHD), particularly in pediatric populations. This procurement supports the Defense Health Agency's pharmaceutical supply chain and reflects DLA's ongoing need to source specialized medications for military healthcare systems. AmerisourceBergen's substantial IDC vehicle enables it to fulfill federal medical supply requirements across multiple therapeutic domains, supporting defense health programs globally through flexible delivery mechanisms that accommodate fluctuating demand for critical pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DB25FSBWY?
SPE2DB25FSBWY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FSBWY worth?
The government has obligated $1,860 on SPE2DB25FSBWY.
Is contract SPE2DB25FSBWY an order under another contract?
Yes. SPE2DB25FSBWY is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSBWY competed?
The extent of competition for SPE2DB25FSBWY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award